doi: 10.1016/s0196-9781(00)00252-7.
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor
Affiliations
- PMID: 10998549
- DOI: 10.1016/s0196-9781(00)00252-7
Item in Clipboard
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor
Peptides.
2000 Jul.
Abstract
The nociceptin/orphanin FQ (N/OFQ) receptor (e.g. the human ortholog ORL1) has been shown to be pharmacologically distinct from classic opioid receptors. Recently, we have identified buprenorphine as a full ORL1 agonist using a reporter gene assay. For further functional analysis, buprenorphine's effects on ORL1 receptors were investigated using a K(+) channel (GIRK1) assay in Xenopus oocytes and GTPgammaS assay in CHO-K1 membrane preparations. In both assays, buprenorphine behaved as a partial agonist compared to nociceptin itself. The N/OFQ agonism of buprenorphine might contribute to actions of buprenorphine in pain models in vivo beside its mu- or kappa-opioid receptor mediated effects.
Similar articles
-
Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.J Pharmacol Exp Ther. 2001 May;297(2):688-95. J Pharmacol Exp Ther. 2001. PMID: 11303059
-
N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.J Pept Res. 2003 Nov;62(5):191-8. doi: 10.1034/j.1399-3011.2003.00077.x. J Pept Res. 2003. PMID: 14531842
-
Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.J Chem Neuroanat. 2003 Jul;25(4):233-47. doi: 10.1016/s0891-0618(03)00032-2. J Chem Neuroanat. 2003. PMID: 12842269
-
Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray.J Biomed Sci. 2000 May-Jun;7(3):232-40. doi: 10.1007/BF02255471. J Biomed Sci. 2000. PMID: 10810242 Review.
-
Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.Vitam Horm. 2015;97:1-55. doi: 10.1016/bs.vh.2014.10.001. Epub 2015 Jan 14. Vitam Horm. 2015. PMID: 25677767 Review.
Cited by
-
The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.Curr Top Med Chem. 2011;11(9):1151-6. doi: 10.2174/156802611795371341. Curr Top Med Chem. 2011. PMID: 21050175 Free PMC article. Review.
-
Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.Psychopharmacology (Berl). 2008 Jun;198(2):167-80. doi: 10.1007/s00213-008-1112-0. Epub 2008 Mar 7. Psychopharmacology (Berl). 2008. PMID: 18324390
-
Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency.Viruses. 2021 Jul 27;13(8):1472. doi: 10.3390/v13081472. Viruses. 2021. PMID: 34452338 Free PMC article.
-
A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.J Addict Med. 2014 Sep-Oct;8(5):315-26. doi: 10.1097/ADM.0000000000000045. J Addict Med. 2014. PMID: 25221984 Free PMC article. Review.
-
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.Pharmacol Rev. 2016 Apr;68(2):419-57. doi: 10.1124/pr.114.009209. Epub 2016 Mar 8. Pharmacol Rev. 2016. PMID: 26956246 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
